EBM

Eminence Business Media

Thursday, September 26, 2024

6th Annual Pharma Manufacturing & Automation Convention 2024


The pharma industry is undergoing a transformative evolution with the integration of advanced manufacturing technologies and automation systems. In the 2-day 6th Annual Pharma Manufacturing and Automation Convention 2024 program focused on embracing automation and innovation; leaders, experts, and professionals are set to explore the latest trends, challenges, and advancements shaping the future of pharma. Eminence Business Media has scheduled the conference for October 17th – 18th, 2024 at Hotel Westin Mindspace, Hyderabad.

Day one of the conference will delve into cutting-edge topics such as Industry 4.0 implementation strategies, advanced automation technologies, data integrity in manufacturing processes, and compliance requirements. Discussions will centre around harnessing the power of robotics, artificial intelligence, and lean manufacturing principles to optimize production processes and enhance operational excellence.

Day two will pivot towards practical insights on IT infrastructure integration, regulatory compliance considerations, and predictive maintenance strategies for automated systems. Case studies and best practices in robotics and AI applications will be shared, emphasizing the importance of seamless integration and quality assurance in pharmaceutical manufacturing.

Attendees can expect a deep dive into the regulatory landscape governing automated manufacturing, ensuring that compliance and quality standards are met across API manufacturing and formulation companies. This comprehensive agenda aims to equip industry professionals with the knowledge and tools needed to thrive in the era of digital transformation and innovation within the pharmaceutical manufacturing sector. 

 

Why to Attend:

Expert Speakers: Engage with a line-up of distinguished speakers, including industry veterans, innovators, and experts who have spearheaded transformative initiatives. Their first-hand experiences and knowledge will provide invaluable guidance for attendees.

Interactive Q&A Sessions: Participate in interactive Q&A sessions with speakers and panellists. This is a unique opportunity to directly engage with thought leaders, ask questions, and gain personalized insights that address your specific challenges and concerns.

Real-World Case Studies: Dive into real-world case studies that showcase successful implementations of automation in pharmaceutical manufacturing. Learn from practical examples that demonstrate how automation has improved efficiency, quality, and compliance.

Networking Opportunities: Connect with professionals, peers, and potential collaborators from across the pharmaceutical and automation industries. Forge meaningful relationships, exchange ideas, and explore potential partnerships that could drive your projects forward.

Future Insights: Gain a glimpse into the future of pharmaceutical manufacturing. Delve into discussions about emerging technologies, AI-driven processes, and their potential impact on the industry's evolution.

Networking Reception: Join us for a lively networking reception where you can relax, unwind, and continue conversations in a casual setting. Forge connections, exchange business cards, and build relationships that extend beyond the conference.


Who will Attend: From CXOs, Managing Directors, Presidents, and Vice Presidents to Sr. GMs, GMs and mid-level management, everyone can reap the benefits of this platform to learn and network with industry peers stalwarts.

           Manufacturing

           Production

           Automation

           Tech Transfer

           Quality

           IT

           Academia

Pharma Manufacturing & Automation Excellence Awards 2024: Honoring the Visionaries Behind Pharma's Transformational Growth

Driven by global demand, generics production, and increased domestic investment, India's pharma manufacturing sector has grown by 9% to 12% annually over the past two years. Automation in the industry has also surged, with 15% to 18% annual growth, as companies embrace digital technologies for greater efficiency and innovation.

Fueled by the global demand for innovative solutions, enhanced production capabilities, and the rise of automation technologies, the industry has seen remarkable advancements. Automation in pharma has particularly surged, streamlining processes and driving unparalleled efficiency, compliance, and productivity.

Amidst this transformative growth, the Pharma Manufacturing & Automation Excellence Awards 2024 is set to honor the visionaries and organizations who have propelled the industry forward. Scheduled for October 18th, 2024, at the prestigious Hotel Westin Mindspace, Hyderabad, this event serves as a tribute to the brilliance and innovation shaping the future of pharma manufacturing.

This year’s awards are centered around the theme "Accelerating P.A.C.E.² for Manufacturing & Automation Excellence," reflecting the focus on Productivity, Automation, Compliance, Efficiency, and EHS as key drivers of industry success. With 21 categories spanning both individual and organizational achievements, the awards celebrate the pioneering efforts that have revolutionized production, operations, and IT manufacturing within pharma.

What makes these awards stand out is their unwavering commitment to integrity and fairness. Judged by an elite panel of experts, the process is transparent and unbiased, ensuring that only the most deserving candidates receive recognition for their contributions.

In addition to celebrating excellence, the event also serves as a premium gathering for networking and collaboration among the industry’s elite. Leaders from across the sector will come together to discuss the future of pharma manufacturing, exchange ideas, and build partnerships.

For more information and to submit nominations, visit www.pmaeawards.com. Be part of this prestigious event and celebrate the future of pharma manufacturing!

Monday, July 29, 2024

2nd Annual Pharma Impurity Conclave 2024: Unveiling innovations & anticipating breakthroughs

The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety, efficacy, stability, and the quality of the drugs. To understand the challenges faced by scientists and analytical R&D experts to rid of residual solvents, degradants, or process related impurities, this conclave facilitates knowledge sharing, best practices dissemination, and regulatory updates to ensure practical understanding of those aspects and encourages the highest standards of product quality and patient safety. Ultimately, the 2nd Annual Pharma Impurity Conclave 2024 by Eminence Business Media, scheduled for September 12th – 13th at Hyderabad, serves as a critical platform for the industry professionals to address to those pressing needs for stringent impurity control in drug manufacturing.

Addressing Key Challenges in Pharmaceutical Impurities
Pharmaceutical impurities, whether they arise during the manufacturing process or through degradation over time, can pose significant risks to patient safety. The regulatory landscape governing these impurities is complex and continually evolving. 2nd Annual Pharma Impurities Conclave 2024 aims to provide attendees with the latest insights and practical strategies to navigate these challenges effectively.

A Stellar Line-Up of Expert Speakers
The event will feature a distinguished line-up of speakers from regulatory bodies and leading pharma companies. By bringing together scientists, regulatory experts, and industry leaders, the conclave is to foster collaboration and innovation in impurity analysis, detection, and control strategies.

Key Topics and Sessions
Participants can look forward to a comprehensive agenda that covers a wide range of topics related to pharmaceutical impurities:

Regulatory Updates: Detailed discussions on the latest guidelines from MHRA, FDA, EMA, and ICH, with a focus on permissible impurity levels and compliance requirements.

Analytical Techniques: Sessions on cutting-edge analytical methods for detecting and quantifying impurities, including advancements in mass spectrometry and chromatography.

Risk Assessment and Management: Expert-led discussions on risk assessment frameworks and best practices for managing impurities to ensure patient safety.

Case Studies: Real-world examples of impurity identification, mitigation strategies, and successful regulatory submissions.

Genotoxic Impurities: Special focus on the detection, evaluation, and control of genotoxic impurities, which can pose significant risks even at low levels.

Networking and Collaboration Opportunities
The conclave will also provide ample opportunities for networking and collaboration. Attendees can engage with peers, exchange ideas, and build professional relationships during dedicated networking sessions, panel discussions, and interactive workshops. The event aims to foster a collaborative environment where industry stakeholders can share knowledge and work together to advance the field of pharmaceutical quality control.

Join at the 2nd Annual Pharma Impurities Conclave 2024
Whether you are an Analytical R&D professional, QC expert, or researcher in the pharma, the 2nd Annual Pharma Impurities Conclave 2024 is an event you won't want to miss. Join us to stay at the forefront of developments in pharmaceutical impurities, gain valuable insights from industry leaders, and contribute to the ongoing effort to ensure the safety and efficacy of drug products.

For more information and to register, please visit www.pharmaimpurities.com

Cracking the Code of Cleaning Validation with 4th Annual Cleaning Validation 2024 : A Practical Approach


For pharma, maintaining stringent cleaning standards is non-negotiable. The stakes are high, and the margin for error is slim. Cross-contamination can compromise product quality, endanger patient safety, and lead to costly regulatory penalties. Despite countless discussions, cleaning validation continues to be a burning issue, frequently cited in FDA Form 483 observations.

Recognizing these challenges, Eminence Business Media is proud to announce the 4th Annual Cleaning Validation 2024 – A Practical Approach. This event promises to equip you with the knowledge and skills needed to tackle cleaning validation head-on, ensure compliance, and enhance product safety.

Why This Event Stands Out
Comprehensive Learning Experience: Over two action-packed days, delve into the core aspects of cleaning validation. From theoretical foundations to hands-on practical sessions, this workshop covers everything you need to know. Expect detailed discussions on effective cleaning practices, robust validation procedures, and meeting stringent regulatory requirements.

Practical Insights and Case Studies:
Theory meets practice at our workshop. Engage with real-life case studies and interactive simulations that mirror industry scenarios. Understand emerging strategies for cross-contamination control in multi-product facilities through true-to-life learning environments.

Expert-Led Sessions:
Learn from the best in the field. Our lineup of esteemed speakers brings their extensive experience and knowledge to the table. Participate in a fireside chat exploring the challenges of cleaning validation and strategies for navigating FDA 483 observations.

MACO Calculations Mastery:
The mini-masterclass on Maximum Allowable Carryover (MACO) calculations. Gain in-depth knowledge of calculation methodologies and practical applications, ensuring compliance and maintaining product safety. Test your understanding with an engaging quiz and hands-on exercises.

Interactive and Engaging Format:
We believe in making learning interactive and engaging. Participate in live Q&A sessions, group activities, and practical exercises designed to reinforce your understanding and address your specific queries. Enjoy networking breaks to connect with peers and industry leaders.

Continuous Learning and Support:
The learning doesn’t stop after the event. Benefit from a follow-up virtual session designed to address any questions that arise as you implement what you've learned. Additionally, enjoy six months of extended support, ensuring continuous learning and application in your professional life.

Who Should Attend:
This workshop is ideal for professionals overseeing cleaning validation programs, including executives, directors, managers, specialists, engineers, and other experts in engineering, cleaning validation, manufacturing science and technology, process monitoring and control, quality assurance/quality control, risk management, audit, documentation and analysis, and microbiology.

Don’t miss this opportunity to enhance your cleaning validation expertise and safeguard your processes against regulatory scrutiny. Join all at the Radisson Blu Mumbai International Airport for an event that promises to be insightful, practical, and transformative. Register now and take the next step towards mastering cleaning validation in the pharmaceutical industry.

Saturday, April 13, 2024

The Nitrosamine Advanced Workshop 2024 to be held on May 9th - 10th, 2024 at Radisson Blu Mumbai

The presence of Nitrosamines, which are probable human carcinogens, has been an evolving challenge facing the pharmaceutical industry. Regulators became first aware of this impurity in mid – 2018, when NDMA was found in blood pressure medicine known as sartans. Ever since, the pharmaceutical industry has been working hard to mitigate the formation of Nitrosamines Impurities.

With the extensive research conducted by us, we have identified certain key challenges around nitrosamine formation, faced by the pharma manufacturers. We bring to you “Nitrosamine Advanced Workshop 2024” where we have experts from across the industry sharing their experience and expertise gained in this evolving concern.

To be held on May 9th – 10th, 2024 at Radisson Blu Mumbai International Airport, this workshop provides a comprehensive and in-depth exploration of nitrosamines, covering both updated regulatory guidelines and analytical understanding, and allowing participants to engage in practical discussions, case study solving sessions and hands-on learning experience. Join us to network with your industry peers and experts, discuss your challenges and get some practical solutions.

Why Attend:

1. Understand the ever-changing situation with Nitrosamines.
2. Discuss the evolving regulatory updates w.r.t Nitrosamines.
3. Dedicated time for Q & A to discuss and clarify your doubts.

Who Can Attend:

Designation:

             Managing Director
•             Director
•             CXO’s
•             President
•             Sr. VP’s
•             VP’s
•             GM’s
•             Sr. Managers
•             Managers
•             Professionals from:

Department:

             Analytical R & D
•             R & D
•             Quality Assurance
•             Quality Control
•             Manufacturing
•             Anyone handling Nitrosamine related Impurity profiling or monitoring.

Advance DoE Workshop 2024 to be held on May 9th & 10th, 2024 @ Hotel Radisson Blu Mumbai

For pharma and biopharma companies, building quality into your products from an early stage is a key factor in regulatory approval and market success. Thus, the FDA mentions “Design of Experiments” (DoE) as an essential tool for achieving both regulatory compliance and faster time to market. To help you build quality into your process as outlined by ICH Q8, Q9, and Q10, Eminence Business Media is planning a two-day robust training program on “Advance DoE Workshop 2024” on May 9th – 10th. 2024 focuses on Towards Implementing Pharma QbD: Recent Paradigms and Techniques of Quintessential DoE.

Here, our trainers will help you learn concepts of Advanced Level Statistical Concepts required to Optimize Processes & achieve Product Robustness. The 2-day program will help you learn:

             Plan, Design, Conduct, and Analyse experiments efficiently and effectively
•             Use response surface methods for system optimization as a follow-up to successful screening.
•             Use experimental design tools for computer experiments
•             Use software tools to create custom designs based on optimal design methodology

How will it help in your daily work?

             More insight and knowledge of the design of experiments leads to improved process variation, performance aligned with planning, shorter development times, more reliability and reduced costs.

What’s Next?

             Participants make better choices and schedules for experiments.
•             Participants can detect and discover interruptions early in the production process.
•             Participants can interpret test results in a more precise and complete fashion.

Who Attend?

Key Process Owners & core team members from the following departments of Pharma & Life Sciences

             Research & Development
•             Formulation & Development
•             Process Excellence
•             Professional scientists, researchers
•             Improvement engineers and managers involved in quality engineering
•             S.Q.C / S.P.C - production, Laboratory and quality assurance and regulatory affairs

Pharma Quality Excellence Awards 2024 to be held at Hotel Novotel Mumbai

The Pharma Quality Excellence Awards 2024 scheduled for April 26th in Hotel Novotel, Airport Road, Mumbai, is a prestigious event aimed at recognizing and celebrating the exceptional achievements of quality departments within the pharmaceutical industry. Eminence Business Media acknowledges remarkable contributions and unwavering dedication in the industry, and this award ceremony serves as a distinguished platform to recognize and appreciate the unwavering dedication, innovation, and commitment of individuals and teams who have demonstrated exceptional performance in upholding the highest standards of quality, safety, and efficacy in pharmaceutical products.

The awards program boasts a meticulously assembled Board of Jury comprising renowned industry experts, thought leaders, and regulatory authorities. The esteemed panel of judges brings a wealth of experience and expertise in quality management, regulatory compliance, and pharmaceutical best practices. Their collective insight and discernment ensure a rigorous and impartial evaluation process, guaranteeing that the most deserving individuals and teams receive the recognition they merit.

The 2024 edition of the Pharma Quality Excellence Awards will convene industry leaders, quality professionals, and stakeholders to celebrate excellence in a wide array of categories, including quality control, quality assurance, regulatory affairs, compliance, and overall quality leadership. This event aims to showcase best practices, cutting-edge techniques, and transformative initiatives that have significantly contributed to elevating quality standards across the pharmaceutical landscape.

By acknowledging and appreciating the efforts of quality professionals, the Pharma Quality Excellence Awards 2024 seeks to inspire a culture of excellence, foster innovation, and drive continuous improvement within the pharmaceutical industry. Through this esteemed platform, exceptional individuals and teams will gain well-deserved recognition for their pivotal role in ensuring the safety and efficacy of pharmaceutical products, ultimately advancing global public health.

EVENT INFORMATION:

EVENT: Pharma Quality Excellence Awards 2024

DESCRIPTION: The Pharma Quality Excellence Awards 2024 is a prestigious event aimed at recognizing and celebrating the exceptional achievements of quality departments within the pharmaceutical industry.

VENUE:  Hotel Novotel Mumbai International Airport
ON:  April 26th, 2024 - 7 PM
CONTACT: Shravan Nair
CONTACT NUMBER: +91 7517 672 770
CONTACT EMAIL: shravan@eminencemedia.in
URL: https://thepharmaawards.com

4th Annual Pharma GMP and Quality Management 2024

Following the resounding success of its 3rd edition, Eminence Business Media proudly presents the 4th Annual Pharma GMP and Quality Management 2024, scheduled for April 25th – 26th at Hotel Novotel, Airport Road Mumbai.

With the theme Transforming roles of ‘C’ in CGMP – Evolving & Optimizing Quality Systems, this confluence brings pharmaceutical experts to address the most pressing GMP practices and challenges with the intervention of Compliance, Culture, Communication, Class, and Chatbots….

This is event dedicated to fostering the exchange of knowledge, embracing best practices, and enhancing the capabilities of pharmaceutical companies in India, empowering them to adopt globally recognized standards with a strong emphasis on the technical intricacies of pharma quality.

This highly anticipated occasion will provide a comprehensive platform for industry experts to converge and delve deep into the technical nuances of Good Manufacturing Practices (GMP) and quality management.


The session is aiming to showcase in-depth discussions and immersive training sessions led by renowned thought leaders and practitioners to gain practical, technical skills and knowledge essential for ensuring compliance, product quality, and operational efficiency in pharma manufacturing.


To enhance the learning experience and better understanding and implementation, a virtual session is to take place on April 13th, 2024 with presentation based learning and dedicated Q&A round with 3 industry experts.


Let's connect and collaboratively shape the success of the 4th Annual Pharma GMP and Quality Management 2024.

Why Attend?

  •  In-depth discussions, case studies, group discussions and dedicated Q&A session for enhanced practical learning.
  •  Explore the impact of recent innovations in GMP & Quality Management 
  •  Gain insights through interactive live Q&A sessions and enjoy the advantage of extended 6-month support for continuous learning.
  •  Follow up virtual learning session with presentations and dedicated Q&A round 15 days after the conference.
  •  Network with your industry peers and understand what they do differently.

EVENT INFORMATION:

EVENT: 4th Annual Pharma GMP & Quality Management 2024

DESCRIPTION: This is an event dedicated to fostering the exchange of knowledge, embracing best practices, and enhancing the capabilities of pharmaceutical companies in India, empowering them to adopt globally recognized standards with a strong emphasis on the technical intricacies of pharma quality.

VENUE:  Hotel Novotel Mumbai International Airport
FROM:  April 25th, 2024 - 8:30AM
TO: April 26th, 2024 - 5:30PM
CONTACT: Shravan Nair
CONTACT NUMBER: +91 7517 672 770
CONTACT EMAIL: shravan@eminencemedia.in
URL: https://www.gxpqualitymanagement.com

Friday, April 12, 2024

Naxnova acquires Austria based Advanced Thermal Technologies (ATT)

Naxnova, a global leader in surface augmentation and technology solutions, formerly known as Classic Stripes, announced the successful acquisition of Advanced Thermal Technologies (ATT), a pioneer in thermal management solutions based in Austria, today. This strategic acquisition, quick on the heels of the acquisition of the Belgium based Quad Industries, marks another significant step forward in Naxnova's expansion strategy reinforcing their commitment towards delivering innovative solutions to customers worldwide.

ATT has built a reputation for design, development and manufacturing in Advanced Driver Assistance Systems (ADAS) Sensor and Camera Heating Solutions, Vehicle Cabin Solutions, Battery Heating Solutions, Battery Diagnostic Solutions, Seat Sensing & Heating Solutions, etc., serving a diverse range of industries including automotive, aerospace, retail and building. With world-class R&D capabilities and a track record of servicing marquee customers worldwide that includes prestigious OEM brands such as Porsche, Airbus, Daimler, Valeo, among others, ATT brings invaluable expertise and experience to the Naxnova family. Together with Advanced Thermal Technologies, the team aims to step up their offerings and deliver even greater value to customers and stakeholders worldwide.

Commenting on the second acquisition in the last 30 days, Mr. Salil Musale, Managing Director, Naxnova, shared, "This acquisition strengthens Naxnova's commitment to innovation and customer delight. By combining our strengths with those of Advanced Thermal Technologies, we aim to accelerate product development, expand market reach, and create new opportunities for collaboration and partnership. These ingenious solutions in the field of Thermal Management will become a huge requirement for OEMs globally to ensure safety monitoring, and enhance human comfort. ATT stands out as one of the very few companies that have advanced technology in thermal science.”

“With this acquisition, we aim to commercialise these products with our current customers and new customers in India. This acquisition combined with our earlier announced acquisition of Quad Industries, Belgium is a perfect example of our Hon’ble Prime Minister’s vision of Design and Make in India for the World,” he further added. 


By integrating ATT's cutting-edge technologies and expertise into Naxnova's portfolio, the team is poised to deliver enhanced value to our customers across various sectors. This acquisition not only strengthens their capabilities but also paves the way for aggressive development and commercialization of next-generation thermal management solutions for customers globally, especially in India.

In response to the acquisition, the founders of Advanced Thermal Technologies (ATT) expressed their enthusiasm and optimism. They stated, "Joining forces with Naxnova presents an exciting opportunity for us to further expand our reach and capabilities. We are proud of the reputation we have built in delivering innovative thermal management solutions to esteemed clients worldwide, and we are confident that together with Naxnova, we can achieve even greater success."

They continued, "Naxnova's commitment to innovation and customer satisfaction aligns perfectly with our own values, and we believe that this partnership will enable us to accelerate product development and offer enhanced value to our customers across various industries."

This second acquisition marks a new chapter of growth and innovation for the home grown company. While the recently acquired Belgium-based Quad Industries, along with ATT, will create a value chain leveraging the synergies between all three companies to provide innovation and next-generation solutions for customers on a global level.

Naxnova (previously, Classic Stripes) the flagship company of the Astarc Group, is a design & technology company providing new-generation solutions to global OEMs in the Automotive, Consumer Durables & Appliances industries in India. The global design technology organization provides a diverse product range of integrated surface augmentation solutions that includes decals, flexible 3D badges, overlays, smart surfaces and electronic solutions.  The company is a frontrunner in India to have rapidly advanced towards the research, product development, and commercialization of products enabled by printed electronics technology.

Operating from three state-of-the-art manufacturing facilities in India, Naxnova is creating a global and future-forward design and technology-first company with world-class manufacturing capabilities. The brand aims to achieve this through aggressive expansion and bolt-up acquisition plans globally, with next-generation products and solutions integrated with printed electronics technology that brands truly look for. Besides automotive, consumer goods and appliances, Naxnova will very soon be entering the medical devices & wearables industry. Naxnova prides itself on a dedicated workforce of over 1000 professionals serving customers in more than 16 countries, globally. In the automotive sector, the brand serves prestigious clients such as Yamaha, Ford, Honda, Suzuki, Tata Motors, Harley Davidson, KTM, Toyota, Hero, Bajaj, among others. Within the consumer durables segment, Naxnova serves leading names like Panasonic, Samsung, and more.

Thursday, April 11, 2024

Embracing the Intelligent Revolution: The Future of Labels and Packaging


The print industry has undergone a profound transformation over the past two decades. What was once dominated by long production series has now shifted towards shorter runs of customized products, tailored to meet the diverse needs and preferences of modern consumers. The demand for customization and variety continues to soar, yet with this surge in diversity comes a heightened level of complexity for the Labels & Packaging industry.

In an era where consumer habits evolve rapidly, regulatory requirements fluctuate, and e-commerce reshapes distribution channels, the ability to adapt quickly is key. Flexibility is the key to navigating this dynamic landscape, and digital technologies have emerged as a crucial enabler of agility.

Today, nearly one in two presses sold in the sector is digital. Within the next decade, we can anticipate this will increase to two in three. HP Indigo has been a pioneer, introducing liquid electrophotography (LEP) in the 1990s, which sparked this revolution and the results are evident today. The transition from conventional to digital printing has allowed for unprecedented flexibility in meeting client demands, with digital presses paving the way for swift adaptation to varying orders at no additional cost. However, all of this is ultimately just history.

As we look ahead, the real question is: What does the future hold for the Labels & Packaging industry? How will professionals in this sector operate in the coming years, and what transformations lie on the horizon? While no crystal ball can predict with certainty, several trends and developments offer insights into the path forward.

Digitalization will define the entire process
Digitalization is set to permeate every aspect of the production process, especially downstream. While we continue to see new entrants’ breakthrough and some finishers go 100% digital, there is still a way to go when compared to the 2000 HP Indigo machines operating in Labels & Packaging.

We know that by embracing digital processes across the production chain, from printing to the finished product, the industry stands to gain significant advantages in terms of productivity, waste reduction, and sustainability. Orders would be executed more quickly and the entire system would move towards zero stock and zero waste, less warehousing across the supply chain and ultimately greater efficiency and reduced environmental impact for both converters and their clients. A 100% digital process would lead to a decrease in quality defects, errors that result in waste, and value destruction.

Intelligent production lines are on the rise. We’re looking at a future where a job can be completed in just a few hours and ready to be delivered just a few later. But achieving this vision of a fully digitalized production ecosystem requires overcoming two critical challenges: standardization of file formats and seamless communication between machines. The ability to work from unified digital files containing both technical specifications and commercial data will streamline order management and facilitate rapid response to client needs. Similarly, enhanced connectivity between machines will enable real-time monitoring and optimization of production processes, driving efficiency and performance. These two challenges are by no means insurmountable and drupa 2024 will certainly be a moment where we’ll hear and see more.

In the packaging industry, information flows at the machine level transferring data across the production flow and to Human-Machine Interfaces (HMIs) so that the operators can control the machine and monitor its performance. This data also feeds into ERP systems and into a cloud infrastructure where it’s used to understand if a machine, a line, or even entire factories are operating well or not. The calculation of profitability relies on this today. Major corporations beyond printing, with dozens of factories worldwide, operating hundreds of production lines use this information to compare the performance of their sites. Very soon we could anticipate converters will operate in a similar manner - measuring the performance of their production lines, the idle rate of their presses, the number and type of breakdowns they experience, consumables consumption, job execution time, and production costs.

Robotics and intelligent systems will manage the flows
In an era where product differentiation and on-demand has become king, the number of substrates, films, primers, inks, and other coatings to be purchased, stored, and used is ever-increasing, efficient production cannot overlook more optimal management of all the flows of materials and supplies. As we look towards the future, the role of automation and robotics in managing material flows within factories will also become increasingly prominent. Accurate and real-time records of everything entering and leaving the production floor are critical, and as we look forward, we can expect the ERPs of printing companies will increasingly integrate traceability of these elements and finished products more efficiently, from the moment they leave the machines to the warehouse or the reconciliation area for swift shipping.

Logistics within printing production floors will also evolve to accommodate transport vehicles. Automated Guided Vehicles (AGVs) and Autonomous Mobile Robots (AMRs) are poised to revolutionize logistics within printing facilities, offering benefits such as improved inventory management, enhanced productivity and reduced reliance on human labor. By integrating these technologies into production workflows, manufacturers can achieve greater efficiency and responsiveness to changing demands. The automotive industry is already at the forefront of using these systems, while the printing & packaging industry is just beginning to adopt them. In the next five to ten years, we expect to see our industry follow suit.

And the ultimate layer?
After the flows between converters and packers, the last stage of this evolution will involve the retailers and the consumers. In about a decade we can expect entire production flows to be managed automatically by machines and robots, with a minimum of human intervention. Traceability will be complete. Both digital and physical exchanges between consumer’s order to retailers and to factories and warehouses will be seamless.

It's indeed only a matter of time that it will be the consumer who triggers the order at the very moment they purchase the product in the store or on-line. The financial transaction will initiate a series of reverse orders to go up the chain the moment a product sells, from the retailer to the producer, up to the ERP of the converter, which will instruct the press to manufacture the appropriate type of packaging and label. In a matter of days, the converter can manufacture all the required packaging and labels for the sold products and ship them to the packager who will have manufactured the products and sent them to the retailer, allowing him to almost replenish his stocks instantly. With these digital flows and operating a zero-stock model, printers will be able to better manage resource, embrace sustainability and ultimately, embrace higher profitability. Is it possible to do better?

AI will play a prominent role
Finally, the future of printing cannot overlook Artificial Intelligence (AI). The integration of AI promises to further enhance operational efficiency and quality control - detecting errors and correcting the work of printing, embellishment, or cutting systems on its own. AI-driven algorithms can also optimize machine performance, predict maintenance needs, and even assist in decision-making processes. From quality control to predictive maintenance and supply chain optimization, AI holds the potential to revolutionize every aspect of the printing and packaging industry.

Label converters are on the front line
In this rapidly evolving landscape, label and packaging is at the forefront of innovation. As the first sector to undergo its digital revolution thirty years ago, the industry is well-positioned to embrace emerging technologies. The next twenty years promise a paradigm shift in the way printing and packaging are conceptualized and executed. With digitalization, automation, and AI-driven optimization at the forefront, the industry is poised to enter a new era of quality, versatility, productivity, sustainability, and profitability. As we navigate this intelligent revolution, one thing is clear: the future of printing and packaging is bright, and the possibilities are limitless.

By Haim Levit: SVP & Division President, HP Industrial Print